These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 22577871

  • 1. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study.
    Jørgensen KK, Lindström L, Cvancarova M, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM.
    Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Torres J, Pineton de Chambrun G, Itzkowitz S, Sachar DB, Colombel JF.
    Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
    [Abstract] [Full Text] [Related]

  • 4. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia.
    Lindström L, Boberg KM, Wikman O, Friis-Liby I, Hultcrantz R, Prytz H, Sandberg-Gertzén H, Sangfelt P, Rydning A, Folvik G, Gangsøy-Kristiansen M, Danielsson A, Bergquist A.
    Aliment Pharmacol Ther; 2012 Feb; 35(4):451-7. PubMed ID: 22221173
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High lifetime risk of cancer in primary sclerosing cholangitis.
    Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR.
    J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
    [Abstract] [Full Text] [Related]

  • 7. Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Imam MH, Thackeray EW, Lindor KD.
    Colorectal Dis; 2013 Feb; 15(2):198-203. PubMed ID: 22712545
    [Abstract] [Full Text] [Related]

  • 8. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
    Gorgun E, Remzi FH, Manilich E, Preen M, Shen B, Fazio VW.
    Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
    [Abstract] [Full Text] [Related]

  • 9. Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.
    Charatcharoenwitthaya P, Angulo P, Enders FB, Lindor KD.
    Hepatology; 2008 Jan; 47(1):133-42. PubMed ID: 17992695
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Jan; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 12. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Manninen P, Karvonen AL, Laukkarinen J, Aitola P, Huhtala H, Collin P.
    Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
    [Abstract] [Full Text] [Related]

  • 13. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.
    Jørgensen KK, Lindström L, Cvancarova M, Karlsen TH, Castedal M, Friman S, Schrumpf E, Foss A, Isoniemi H, Nordin A, Holte K, Rasmussen A, Bergquist A, Vatn MH, Boberg KM.
    Clin Gastroenterol Hepatol; 2013 May; 11(5):517-23. PubMed ID: 23333218
    [Abstract] [Full Text] [Related]

  • 14. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ, Nielsen OH, Andersson M, Ainsworth MA, Ytting H, Bélard E, Jess T.
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [Abstract] [Full Text] [Related]

  • 15. Immune-mediated diseases in primary sclerosing cholangitis.
    Lamberts LE, Janse M, Haagsma EB, van den Berg AP, Weersma RK.
    Dig Liver Dis; 2011 Oct; 43(10):802-6. PubMed ID: 21700515
    [Abstract] [Full Text] [Related]

  • 16. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
    Navaneethan U, Kochhar G, Venkatesh PG, Lewis B, Lashner BA, Remzi FH, Shen B, Kiran RP.
    Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
    Loftus EV, Aguilar HI, Sandborn WJ, Tremaine WJ, Krom RA, Zinsmeister AR, Graziadei IW, Wiesner RH.
    Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
    [Abstract] [Full Text] [Related]

  • 19. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC, Ten Hove JR, Castaneda D, Palmela C, Mooiweer E, Colombel JF, Harpaz N, Ullman TA, van Bodegraven AA, Jansen JM, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, Oldenburg B, Itzkowitz SH, Torres J.
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [Abstract] [Full Text] [Related]

  • 20. Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Singh S, Loftus EV, Talwalkar JA.
    Am J Gastroenterol; 2013 Sep; 108(9):1417-25. PubMed ID: 23896954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.